Thomas Emm
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 3
- Rheumatology top 5%
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Cytokine Signaling Pathways and Interactions 2
-
- Pharmacological Effects and Assays 3
-
- Neuroscience and Neuropharmacology Research 2
-
- Epilepsy research and treatment 2
-
- Analytical Methods in Pharmaceuticals 2
- Co-authors
- Swamy YeleswaramWilliam V. WilliamsNaresh PunwaniYvonne LoXuejun ChenJack ShiPeggy ScherleRyan McGee
- Cited by
- GeneticsHematologyRheumatology
- Journals
- The Journal of Clinical Pharmacology (3 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Biomedical Chromatography (1 paper)
- Partner nations
- United States
In The Last Decade
Thomas Emm
16 papers receiving 674 citations
Peers
Comparison fields: 5 of 82
- Genetics 254
- Hematology 219
- Rheumatology 168
- Pharmacology 59
- Oncology 157
Countries citing papers authored by Thomas Emm
This map shows the geographic impact of Thomas Emm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Emm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Emm more than expected).
Fields of papers citing papers by Thomas Emm
This network shows the impact of papers produced by Thomas Emm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Emm. The network helps show where Thomas Emm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Emm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 164 | |
| 2 | 2013 | 27 | |
| 3 | 2011 | 123 | |
| 4 | 2011 | 86 | |
| 5 | 2011 | 25 | |
| 6 | 2010 | 86 | |
| 7 | 2001 | 33 | |
| 8 | 1997 | 4 | |
| 9 | 1996 | 1 | |
| 10 | 1996 | 32 | |
| 11 | 1994 | 2 | |
| 12 | Update on the physical-chemical compatibility of cromolyn sodium nebulizer solution: bronchodilator inhalant solution admixtures. | 1991 | 10 |
| 13 | 1988 | 30 | |
| 14 | 1988 | 4 | |
| 15 | 1987 | 4 | |
| 16 | 1987 | 63 |
About Thomas Emm
Thomas Emm is a scholar working on Genetics, Hematology and Animal Science and Zoology, having authored 16 papers that have together received 694 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Pharmacological Effects and Assays (3 papers), Neuroscience and Neuropharmacology Research (2 papers), Epilepsy research and treatment (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Analytical Methods in Pharmaceuticals (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Genetics (254 citations), Hematology (219 citations) and Rheumatology (168 citations). Thomas Emm has collaborated with scholars based in United States. Frequent co-authors include Swamy Yeleswaram, William V. Williams, Naresh Punwani, Yvonne Lo, Xuejun Chen, Jack Shi, Peggy Scherle, Ryan McGee, Fiona Lee and Henry J. Pieniaszek. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal of Pharmaceutical and Biomedical Analysis, Biomedical Chromatography, Antimicrobial Agents and Chemotherapy and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.